Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombotic Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06523088
What this trial is testing

PN20 in Healthy Adult Volunteers

Who this might be right for
Chemotherapy-induced ThrombocytopeniaImmune Thrombocytopenic Purpura
Chongqing Peg-Bio Biopharm Co., Ltd. 27
Not applicableUnknownNCT01255332
What this trial is testing

Helicobacter Pylori Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura
Cooperative Study Group A for Hematology 26
Large-scale testing (Phase 3)Looking for participantsNCT07700238
What this trial is testing

Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Amgen 126
Large-scale testing (Phase 3)Study completedNCT00774202
What this trial is testing

Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Weill Medical College of Cornell University 17
Not applicableNot Yet RecruitingNCT07310342
What this trial is testing

Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura
University Hospital, Bordeaux 53
Testing effectiveness (Phase 2)Study completedNCT00706342
What this trial is testing

Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Rigel Pharmaceuticals 18
Large-scale testing (Phase 3)Study completedNCT00603642
What this trial is testing

P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 34
Very early researchNot Yet RecruitingNCT07416032
What this trial is testing

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Large-scale testing (Phase 3)Looking for participantsNCT07233213
What this trial is testing

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Grand Shuyang Life Sciences (Chengdu) Co., Ltd. 36
Not applicableStudy completedNCT02085993
What this trial is testing

Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training

Who this might be right for
Immune Thrombocytopenic Purpura
Amgen 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400250
What this trial is testing

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Peking Union Medical College Hospital 28
Not applicableStudy completedNCT04070612
What this trial is testing

National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.

Who this might be right for
CytopeniaAutoimmune Haemolytic AnaemiaThrombocytopenic Purpura, Immune
University Hospital, Bordeaux 122
Large-scale testing (Phase 3)Study completedNCT02077192
What this trial is testing

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 123
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Not applicableStudy completedNCT02042560
What this trial is testing

Study of Immune Thrombocytopenia Pathogenesis:

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Centre Hospitalier Universitaire Dijon 89
Testing effectiveness (Phase 2)Study completedNCT03524612
What this trial is testing

Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT00102739
What this trial is testing

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 99
Testing effectiveness (Phase 2)Looking for participantsNCT06478537
What this trial is testing

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Who this might be right for
Immune Thrombocytopenia
Peking Union Medical College Hospital 56
Testing effectiveness (Phase 2)Study completedNCT05279872
What this trial is testing

Zanubrutinib in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaBruton Tyrosine Kinase
Peking University People's Hospital 20
Large-scale testing (Phase 3)Study completedNCT00749112
What this trial is testing

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Who this might be right for
Idiopathic Thrombocytopenic PurpuraAnemia, Hemolytic, Autoimmune
Hospital Universitario Dr. Jose E. Gonzalez 19
Next Page